Pictet Asset Management (Switzerland)’s Gilead Sciences GILD Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$385M	Buy	4,991,061 +739,901	+17%	+$59M	0.46%	51
2023 Q1	$353M	Buy	4,251,160 +931,921	+28%	+$77.2M	0.44%	54
2022 Q4	$285M	Buy	3,319,239 +39,948	+1%	+$3.16M	0.41%	58
2022 Q3	$202M	Buy	3,279,291 +1,067,966	+48%	+$67.3M	0.3%	96
2022 Q2	$137M	Buy	2,211,325 +60,050	+3%	+$3.72M	0.19%	155
2022 Q1	$128M	Sell	2,151,275 -586,695	-21%	-$37.5M	0.14%	193
2021 Q4	$199M	Sell	2,737,970 -1,644,688	-38%	-$113M	0.2%	151
2021 Q3	$306M	Buy	+4,382,658	New	+$308M	0.34%	77

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s GILD Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Gilead Sciences (GILD) stake by 17% in Q2 2023, buying an estimated $59M and bringing the position to 4,991,061 shares worth $385M. The position accounts for 0.46% of the portfolio, ranked #51.

Pictet Asset Management (Switzerland) first reported a position in GILD in Q3 2021 and has held it in 8 quarters since. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Pictet Asset Management (Switzerland) held 4,991,061 shares of Gilead Sciences worth $385M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 739,901 Gilead Sciences shares in Q2 2023, an estimated $59M.
Gilead Sciences made up 0.46% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #51 holding.
Pictet Asset Management (Switzerland) first reported a position in Gilead Sciences in Q3 2021 and has held it in 8 quarters since.
1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.